Beyond stool: sampling context and inferential scope in gut mechanistic studies
Rebecca LewandowskiSUMMARY
Human gut microbiome research still relies heavily on fecal sampling because stool is noninvasive, scalable, repeatable, and essential for population-level and longitudinal studies. These strengths have made stool central to human microbiome science, but fecal output is not a neutral representation of every intestinal compartment. It reflects material that has persisted through digestion, transport, microbial turnover, host absorption, and distal colonic processing. This distinction becomes important when studies move from detecting microbial associations to explaining localized activity, host-interface interaction, inducible viral states, metabolic flux, or clinical consequences. This review proposes a framework for aligning sampling context with inferential scope across five evidence domains. These include distal output detection, regional luminal measurement, host-interface measurement, linked functional response, and patient-level consequence. The framework is not intended to rank specimen types or require every study to escalate toward invasive sampling. Instead, it clarifies which claims are supported by stool, luminal sampling, mucosal or host-proximal measurements, experimental models, and clinical metadata when used alone or in combination. Prophage induction and fecal short-chain fatty acid measurements are used as examples of a broader methodological issue. Detection in feces can be highly informative, but it does not by itself localize activity, establish mechanism, or demonstrate host consequence. As gut microbiome research increasingly seeks mechanistic explanations, sampling strategy should be treated as part of inference itself.